At the Icahn School of Medicine at Mount Sinai (ISMMS), we conduct groundbreaking research aimed at transformative patient care. Our research is complemented by affiliations with leading scientific institutions across the country.
Rensselaer Polytechnic Institute
In 2013, we formed an academic affiliation with Rensselaer Polytechnic Institute (RPI), a research university known for its strong engineering and computational sciences programs. The Mount Sinai and Rensselaer Collaborative Center for Research Innovation and Entrepreneurship combines RPI’s strong engineering and computational sciences programs with our expertise in biomedical research and clinical care to help create advances in the diagnosis and treatment of human disease.
The Center studies a broad range of conditions, diseases, and related technologies, and explores drug development, stem cell applications, cellular engineering, and computational neurobiology.
Learn more about the ISMMS-RPI affiliation
Stony Brook University School of Medicine
In 2016, the Icahn School of Medicine at Mount Sinai (ISMMS) and Stony Brook University School of Medicine (SBUSOM) signed an agreement to collaborate on education programs and research designed to transform human healthcare. This partnership leverages the excellence in education, innovation, and discoveries of both world class institutions.
By joining forces, we are taking medical education and biomedical research to the next level, fostering synergy across classrooms and research initiatives through joint graduate and medical educational programs, as well as summer undergraduate, graduate, and post-graduate training.
Graduate Center of the City University of New York
The City University of New York is internationally recognized as a premiere public university, comprised of 13 senior colleges, seven community colleges and four graduate schools, including the Graduate Center of The City University of New York (“GCCUNY”). GCCUNY offers over thirty doctoral programs in the arts, humanities, social sciences, and natural sciences, as well as an interdisciplinary Master of Arts in Liberal Studies program encompassing the humanities and social sciences.
GCCUNY and Icahn School of Medicine at Mount Sinai (ISMMS) have developed a number of programs designed to enhance their mutual educational and research goals. These currently include:
- Graduate Student Exchange Program – ISMMS and GCCUNY students can broaden their educational experience by taking courses not offered at their home institution. For ISMMS students, these might include courses in mathematics, engineering, computer science, chemistry, and physics. GCCUNY students in turn have access to a wide range of biomedical courses offered at Mount Sinai.
- Inter-Institutional Glial Biology Initiative – This cooperative program between ISMMS and the Neuroscience Initiative at the Advanced Science Research Center at GCCUNY is designed to catalyze and strengthen scientific interactions relating to glial biology, and to create the first Glial Biology Initiative in New York City. Collaborative research, educational symposia, joint recruitment, and sharing of core resources are key features planned for this relationship.
New York Academy of Medicine
The geographic proximity of ISMMS and the New York Academy of Medicine (NYAM) has fostered informal interactions over the years. In February 2014, ISMMS and NYAM entered into a formal partnership to address significant health issues and policies affecting urban populations. Together, we conduct collaborative research and sponsor educational programs and training relating to a broad range of issues including disease prevention, global health initiatives, health care policy, and genetics and genomics. This affiliation is resulting in grant applications, publications, educational courses, and mentoring opportunities.
Each institution brings a unique history and mission to the relationship, with goals that intersect in fundamentally important ways. Here at Mount Sinai, we draw on a variety of disciplines and programs, including our Departments of Population Health Science and Policy; Family Medicine and Community Health; and Environmental Medicine and Public Health, as well as our multidisciplinary institutes focused on translational epidemiology, and genetics and genomics. Additionally, our Center for Health Equity and Community Engaged Research, our biomedical Informatics team, and our Graduate School of Biomedical Sciences, are helping to bring significant expertise to the relationship.
Baylor Research Institute
Following a period of informal collaboration, in 2007, ISMMS and the Baylor Research Institute (BRI) in Dallas, Texas, forged a formal academic affiliation. Through this partnership, ISMMS faculty, students, and postdoctoral trainees have access to BRI research laboratories and programs, including those studying dendritic cells, the development of cancer, infectious disease vaccines, new therapeutic approaches to autoimmune diseases, and new ways to improve the outcome of organ transplantation. BRI scientists are offered ISMMS faculty appointments to facilitate the exchange of scientific expertise and ideas, and the two institutions are engaging in joint research projects.
BRI conducts translational research on a continuum that runs from bench research to prevention, therapy, and treatment for human diseases. Approximately 500 active investigators are engaged in in drug, device, and vaccine studies, and the greater Dallas-Fort Worth area offers a large and diverse pool of potential research participants.
Biodesign Institute at Arizona State University
The academic affiliation between ISMMS and the Biodesign Institute at Arizona State University focuses on joint research and educational activities in shared areas of expertise, such as cancer, neurological diseases, and chronic conditions. Each brings its unique, complimentary qualities to the partnership.
Brookhaven National Laboratory
Since 2001, ISMMS has collaborated in a variety of areas with Brookhaven National Laboratory (BNL), a prestigious research institution located on Long Island. Primarily funded by the Office of Science of the U.S. Department of Energy, BNL operates cutting-edge, large-scale facilities for studies in physics, chemistry, biology, medicine, applied science, and a wide range of advanced technologies. BNL has approximately 3,000 scientists, engineers, and support staff.
The affiliation’s overarching goal is to develop innovative approaches to understanding, diagnosing, and treating human disease, and to advance drug research and development.